Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 115111
Gene Symbol: SLC26A7
SLC26A7 		0.100 GeneticVariation phenotype GWASCAT Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men. 21897333 2011
Entrez Id: 392843
Gene Symbol: IQCA1L
IQCA1L 		0.100 GeneticVariation phenotype GWASCAT Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial. 31219150 2019
Entrez Id: 30820
Gene Symbol: KCNIP1
KCNIP1 		0.100 GeneticVariation phenotype GWASCAT Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial. 31219150 2019
Entrez Id: 1387
Gene Symbol: CREBBP
CREBBP 		0.100 GeneticVariation phenotype GWASCAT Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial. 31219150 2019
Entrez Id: 100507679
Gene Symbol: MUC22
MUC22 		0.100 GeneticVariation phenotype GWASDB The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598 2010
Entrez Id: 26960
Gene Symbol: NBEA
NBEA 		0.100 GeneticVariation phenotype GWASDB Common genetic variation and the control of HIV-1 in humans. 20041166 2009
Entrez Id: 8676
Gene Symbol: STX11
STX11 		0.100 GeneticVariation phenotype GWASCAT Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial. 31219150 2019
Entrez Id: 84467
Gene Symbol: FBN3
FBN3 		0.100 GeneticVariation phenotype GWASCAT Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial. 31219150 2019
Entrez Id: 28652
Gene Symbol: TRAV30
TRAV30 		0.100 GeneticVariation phenotype GWASCAT Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study. 28447399 2017
Entrez Id: 7148
Gene Symbol: TNXB
TNXB 		0.100 GeneticVariation phenotype GWASDB The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598 2010
Entrez Id: 341880
Gene Symbol: SLC35F4
SLC35F4 		0.100 GeneticVariation phenotype GWASDB Common genetic variation and the control of HIV-1 in humans. 20041166 2009
Entrez Id: 199
Gene Symbol: AIF1
AIF1 		0.100 GeneticVariation phenotype GWASDB The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598 2010
Entrez Id: 9223
Gene Symbol: MAGI1
MAGI1 		0.100 GeneticVariation phenotype GWASCAT Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial. 31219150 2019
Entrez Id: 5460
Gene Symbol: POU5F1
POU5F1 		0.100 GeneticVariation phenotype GWASCAT The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598 2010
Entrez Id: 2915
Gene Symbol: GRM5
GRM5 		0.100 GeneticVariation phenotype GWASCAT Common genetic variation and the control of HIV-1 in humans. 20041166 2009
Entrez Id: 55536
Gene Symbol: CDCA7L
CDCA7L 		0.100 GeneticVariation phenotype GWASCAT Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial. 31219150 2019
Entrez Id: 285834
Gene Symbol: HCG22
HCG22 		0.100 GeneticVariation phenotype GWASDB The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598 2010
Entrez Id: 170679
Gene Symbol: PSORS1C1
PSORS1C1 		0.100 GeneticVariation phenotype GWASCAT Common genetic variation and the control of HIV-1 in humans. 20041166 2009
Entrez Id: 105375015
Gene Symbol: LINC02571
LINC02571 		0.100 GeneticVariation phenotype GWASDB Common genetic variation and the control of HIV-1 in humans. 20041166 2009
Entrez Id: 10150
Gene Symbol: MBNL2
MBNL2 		0.100 GeneticVariation phenotype GWASCAT Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial. 31219150 2019
Entrez Id: 56980
Gene Symbol: PRDM10
PRDM10 		0.100 GeneticVariation phenotype GWASCAT Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial. 31219150 2019
Entrez Id: 677820
Gene Symbol: SNORA38
SNORA38 		0.100 GeneticVariation phenotype GWASDB The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598 2010
Entrez Id: 105375015
Gene Symbol: LINC02571
LINC02571 		0.100 GeneticVariation phenotype GWASDB The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598 2010
Entrez Id: 100130889
Gene Symbol: PSORS1C3
PSORS1C3 		0.100 GeneticVariation phenotype GWASCAT The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. 21051598 2010
Entrez Id: 50854
Gene Symbol: SNHG32
SNHG32 		0.100 GeneticVariation phenotype GWASCAT Common genetic variation and the control of HIV-1 in humans. 20041166 2009